Continuing rearrangement but absence of somatic hypermutation in immunoglobulin genes of human B cell precursor leukemia.
about
Clonal diversity of Ig and T-cell receptor gene rearrangements in childhood B-precursor acute lymphoblastic leukaemia.Leukemia relapse reconsidered from the molecular aspect.Clonal analysis of childhood acute lymphoblastic leukemia with "cytogenetically independent" cell populationsClinical observations on chemotherapy curable malignancies: unique genetic events, frozen development and enduring apoptotic potential.Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects.c-myc hypermutation in Burkitt's lymphoma.The molecular genetics of hematologic malignanciesCharacterization of the immunoglobulin heavy chain complementarity determining region (CDR)-III sequences from human B cell precursor acute lymphoblastic leukemia cells.A human lymphoma cell line with multiple immunoglobulin rearrangements.T-cell receptor alpha and delta gene assembly in B-cell precursor acute lymphoblastic leukemia.Use of oligonucleotide probes directed against T cell antigen receptor gamma delta variable-(diversity)-joining junctional sequences as a general method for detecting minimal residual disease in acute lymphoblastic leukemias.Histologic transformation of follicular lymphoma to diffuse lymphoma represents tumor progression by a single malignant B cellPreferential utilization of specific immunoglobulin heavy chain diversity and joining segments in adult human peripheral blood B lymphocytesRelationship of variable region genes expressed by a human B cell lymphoma secreting pathologic anti-Pr2 erythrocyte autoantibodies.Molecular genetic characterization reveals new subsets of mantle cell lymphoma.Humanization of murine monoclonal antibodies through variable domain resurfacing.The evolution of clonality testing in the diagnosis and monitoring of hematological malignancies.Activation-induced cytidine deaminase acts as a mutator in BCR-ABL1-transformed acute lymphoblastic leukemia cells.Presence of somatic hypermutation and activation-induced cytidine deaminase in acute lymphoblastic leukemia L2 with t(14;18)(q32;q21).Multiple myeloma: why does the disease escape from plateau phase?The V(D)J recombination in acute lymphoid leukemias: a short review.Immunoglobulin somatic variation; studies of receptor editing in a human B cell lymphoma.Identification of cation-independent mannose 6-phosphate receptor/insulin-like growth factor type-2 receptor as a novel target of autoantibodies.Multiple myeloma: new evidence and insights from the immunoglobulin heavy chain gene and phenotypes.Improvement of antigen binding ability of human antibodies by light chain shifting.Burkitt's lymphomas express VH genes with a moderate number of antigen-selected somatic mutations.Alterations in immunoglobulin genes reveal the origin and evolution of monotypic and bitypic B cell lymphomas.Oligoclonal immunoglobulin gene rearrangements in Philadelphia chromosome-positive common acute lymphoblastic leukemia.Age-related patterns of immunoglobulin and T-cell receptor gene rearrangements in precursor-B-ALL: implications for detection of minimal residual disease.Distinctive features of immunoglobulin heavy chain variable region gene rearrangement in multiple myeloma.Molecular analysis of rearranged VH genes during B cell chronic lymphocytic leukemia: intraclonal stability is frequent but not constant.Immunoglobulin gene 'fingerprinting': an approach to analysis of B lymphoid clonality in lymphoproliferative disorders.Maintained rules of development in a mouse B-cell tumor.Cellular origin and extent of clonal involvement in multiple myeloma: genetic and phenotypic studies.Immunoglobulin VH4 gene usage in B lymphoid leukaemias.
P2860
Q33837936-11600A2D-1EA1-407B-AF97-95B85CF7F77DQ34066655-80C5C48D-A3AB-4F26-B807-E51A6200E201Q34575072-344FFDD7-BC26-4996-A302-6DD528049538Q35021459-82BAC600-B0BD-46AD-8075-5B8E81F4F38EQ35134983-0B85C45C-1FBF-4EC0-9273-47ECA99379EFQ35219287-21A85CFF-FD50-47EE-BCA9-B5124BCE120EQ35224361-532329C5-CC5D-4479-A210-8AB215CD1F18Q35598751-9884904A-40E7-4BAE-86D7-E196637EF52DQ35599761-69F8D600-40E5-4D6D-AF7D-125CB1C2B3AEQ35664702-6C83E8F2-8CE0-407F-BCA0-DBC8DDAE39ACQ35818509-7E2AFCC7-7710-4A0F-8ADA-C6EE936924CFQ36229751-D9592356-D17E-4B8A-B310-84355E745482Q36229896-C549FB44-9AA3-49C5-A40B-3E0B677765A6Q36356325-A77703B3-140D-4DAD-96A7-89C735D4A004Q37152738-61749C19-35E1-42F4-8C3D-133EDB14ADBDQ37558400-F22CE69C-D0CA-4C13-B261-B9A68A839252Q38201053-8D8D66A7-7AF8-485D-8334-94DA6A1780C7Q38302008-5A8C0E21-69AA-4EB7-8493-253A6BC5416EQ40478235-E5E3C96D-5A95-41BE-A963-AB75D8924CAAQ40567866-C3BA20ED-32AF-4EA4-ABD2-659C764F8808Q40696900-E75CE43A-6AFD-4267-A5DA-41C3612B8468Q40751321-83DE7ABD-ED25-42F5-ABBB-44BA81722330Q40912672-8AA3B105-92B1-4F0B-9600-8B19A61AE9CEQ40963467-343B031D-8681-4A28-AC41-497BA52094B2Q41775747-5DE0292C-C58D-45C0-8174-E88FB1E697E9Q41828070-8044D934-25ED-4A56-94B4-666D9BA9CD68Q42769380-55FBB402-80FB-455F-8445-9453F5B2657AQ45721054-7D1EE820-A4C1-45E5-9424-4A2D9E531DECQ47629776-B93CCC6B-4F83-4410-BD43-7A5C53800A5CQ48081430-69DE2723-5FD2-4DBD-AC71-E0671065B3AAQ48082308-683ACA88-7E76-4F42-89D2-18232FFFCB9AQ50796956-939BB547-CBE5-4C6A-B2A8-2F9271D1FF20Q52051782-51174EC2-943C-4CE9-ABF9-FE98D389196FQ52215317-15266C2D-E607-4BBC-BC07-D4EEFDF357DDQ52224516-51D8EFA0-B59C-43FF-A15C-C3232E6FF067
P2860
Continuing rearrangement but absence of somatic hypermutation in immunoglobulin genes of human B cell precursor leukemia.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh
1988年學術文章
@zh-hant
name
Continuing rearrangement but a ...... man B cell precursor leukemia.
@ast
Continuing rearrangement but a ...... man B cell precursor leukemia.
@en
type
label
Continuing rearrangement but a ...... man B cell precursor leukemia.
@ast
Continuing rearrangement but a ...... man B cell precursor leukemia.
@en
prefLabel
Continuing rearrangement but a ...... man B cell precursor leukemia.
@ast
Continuing rearrangement but a ...... man B cell precursor leukemia.
@en
P2093
P2860
P356
P1476
Continuing rearrangement but a ...... man B cell precursor leukemia.
@en
P2093
P2860
P304
P356
10.1084/JEM.168.1.229
P407
P577
1988-07-01T00:00:00Z